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Edited by Stuart FergusanAbstract D-Amino acid oxidase (DAAO) has been proposed to
be involved in the oxidation of D-serine, an allosteric activator of
the NMDA-type glutamate receptor in the brain, and to be asso-
ciated with the onset of schizophrenia. The recombinant human
DAAO was expressed in Escherichia coli and was isolated as
an active homodimeric ﬂavoenzyme. It shows the properties of
the dehydrogenase-oxidase class of ﬂavoproteins, possesses a
low kinetic eﬃciency, and follows a ternary complex (sequential)
kinetic mechanism. In contrast to the other known DAAOs, the
human enzyme is a stable homodimer even in the apoprotein
form and weakly binds the cofactor in the free form.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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D-Amino acid oxidase (EC 1.4.3.3, DAAO) was one of the
ﬁrst ﬂavoproteins to be discovered in the mid-thirties of the
last century [1] and has played a prominent role in the develop-
ment of present concepts in mechanistic ﬂavin enzymology. It
is a peroxisomal enzyme that catalyzes the deamination of D-
amino acids to their imino acid counterparts with concomitant
reduction of FAD. The reduced ﬂavin is subsequently reoxidi-
zed by molecular oxygen generating H2O2, and the imino acid
is released into solvent, where it spontaneously hydrolyzes to
the corresponding a-keto acid and ammonia.
In yeast, DAAO is involved in the metabolic utilization of D-
amino acids; in mammals its function is still uncertain. This
question remained largely unanswered until recently when it
was demonstrated that, in brain, the concentration of DAAO
is reciprocal to that of D-serine, a neuromodulator that binds
the glycine modulatory site on the NMDA receptor and that
is needed for glutamate to activate the receptor [2]. The
evidence that by exogenous application of DAAO D-serine deg-
radation attenuates the NMDA receptor-mediated neurotrans-Abbreviations: DAAO, D-amino acid oxidase; hDAAO, D-amino acid
oxidase from human; pkDAAO, D-amino acid oxidase from pig kid-
ney; RgDAAO, D-amino acid oxidase from Rhodotorula gracilis;
D-AA; D-amino acid; IA, imino acid
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serine to regulate NMDA neurotransmission [3].
Schizophrenia aﬀects nearly 1% of the world’s population
and accounts for about 2.5% of health-care costs. In the past
few years several genes linked to schizophrenia susceptibility
have been discovered. The most intriguing discovery has been
a new human gene, G72 on chromosome 13q34. Yeast two-hy-
brid experiments with pLG72 identiﬁed DAAO on 12q24 as an
interacting partner and functional measurements showed that
pLG72 behaves as an in vitro activator of DAAO [4]. In this
way, pLG72 could regulate glutamatergic signaling through
the NMDA receptor pathway. Recombinant pLG72 was re-
cently over-expressed in Escherichia coli and its main proper-
ties have been reported [5].
With the ambitious goal of contributing to the understand-
ing of the correlation between modulation of the enzymatic
activity in this ﬂavoprotein and its possible role in neurotrans-
mission and schizophrenia susceptibility, we investigated the
main properties of human DAAO (hDAAO). The functional
and structural properties of the enzyme from pig kidney
(pkDAAO, 84% sequence identity to hDAAO) and from the
yeast Rhodotorula gracilis (RgDAAO) have been extensively
studied [6–8]. Although the cDNA encoding hDAAO was iso-
lated in 1988 [9], only little has been undertaken to biochemi-
cally characterize the human enzyme, mainly because it was
diﬃcult to express in a heterologous system such as E. coli.
Previous work focused on the artiﬁcial ﬂavinylation of the
apoprotein form of G218C mutant of hDAAO with 8-meth-
ylsulfonyl FAD [10]. Although this work reached the goal of
obtaining a ﬂavinylated enzyme, the wild-type hDAAO has
not yet been functionally characterized in detail.2. Materials and methods
2.1. Protein puriﬁcation
The recombinant hDAAO is expressed in E. coli BL21(DE3) cells
using the pET11b expression vector. The best yield (6.7 mg of
hDAAO/liter of fermentation broth) was obtained by growing the cells
overnight at 37 C following induction with 0.6 mM IPTG during the
exponential phase of growth. hDAAO is puriﬁed using a procedure
modiﬁed from [10], consisting of ammonium sulfate precipitation at
35% saturation, followed by dialysis of the pellet, and anionic ex-
change chromatography on DEAE Sepharose FF at pH 8.0. Following
this procedure, 4.2 mg of hDAAO/liter of fermentation broth with a
85% purity (estimated by SDS–PAGE) was puriﬁed, with an overall
puriﬁcation yield of 60%. For structural experiments, this latter en-
zyme sample was further puriﬁed by gel-permeation chromatography
on a HiLoad Superdex 200 column (Amersham Biosciences). The ﬁnal
enzyme preparation was stored at 20 C in 20 mM Tris–HCl, pH 8.0,
100 mM NaCl, 5% glycerol, 5 mM 2-mercaptoethanol, 40 lM FAD.blished by Elsevier B.V. All rights reserved.
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The oligomeric state of hDAAO was determined by gel-permeation
chromatography on a Superdex 200 (Amersham Biosciences) column
using 20 mM Tris–HCl, pH 8.5, 150 mM NaCl, 5% glycerol, 5 mM
2-mercaptoethanol, and 40 lM FAD as elution buﬀer.
2.3. Spectroscopy
Absorbance data were recorded at 15 C in 20 mM Tris–HCl, 5%
glycerol, and 5 mM 2-mercaptoethanol, pH 8.0, except where stated
otherwise. Dissociation constants for ligands were measured spectro-
photometrically by adding small volumes (1–10 ll) of concentrated
stock solutions to samples containing 1 ml of 10 lM enzyme, at
15 C, and have been calculated from the change in absorbance at
495 and 550 nm for benzoate and anthranilate, respectively. Because
of the weak binding of the coenzyme to the apoprotein moiety, the
reactions also reﬂect the shift of the APO + FAD«HOLO equilib-
rium towards the ﬁnal product upon binding of the ligand. Anaerobic
samples were prepared in anaerobic cuvettes by applying 10 cycles of
evacuation and then ﬂushing with oxygen-free argon. Photoreduction
experiments were carried out at 4 C using an anaerobic cuvette con-
taining 8 lM enzyme, 1 mM EDTA [11,12]. The solution was
photoreduced with a 250 W lamp and the progress of the reaction
was followed spectrophotometrically. The redox potential for the
E-FADox/E-FADred couple of hDAAO was determined by the meth-
od of dye equilibration described by Massey [13]. The enzyme solu-
tion in 20 mM Tris–HCl, pH 8.0, 5% glycerol, was mixed in an
anaerobic cuvette with 0.2 mM xanthine, 5 lM benzyl viologen as
mediator, and 5–8 lM of the appropriate dye [13,14]. The solution
was purged of oxygen, and the reaction was initiated by adding
10 nM xanthine oxidase. The course of the reaction was followed
by recording the spectral course at 15 C. Data were analyzed as de-
scribed in [14,15].
All ﬂuorescence measurements were performed at 15 C and at
0.1 mg/ml protein concentration. The binding constant for the coen-
zyme was determined by titrating 1 lM apoprotein with increasing
amounts of FAD and by monitoring the reconstitution following the
quenching of the protein ﬂuorescence at 340 nm [16]. Circular dichro-
ism (CD) spectra were recorded on a Jasco J-810 spectropolarimeterTable 1
Comparison of the main properties of DAAO from diﬀerent sources
hDAAO
Spectral properties
k455 nm (mM
1 cm1) 12.2
pKa N(3)-H FAD 10.3 ± 0.2
Semiquinone formed (%)
pH 8.0 <5b
pH 8.3 77b
Em (mV), pH 8.0
Free form 100 ± 11
Benzoate complex 134 ± 8
Structural and binding properties
Length (amino acids) 347
Oligomeric state
Holoenzyme Dimeric
Apoprotein Dimeric
FAD binding, Kd (M)
Free form 8 ± 2 · 106
Benzoate complex 3 ± 1 · 107
Benzoate binding, Kd (lM) 7 ± 2
Sulﬁte binding, Kd (lM) 64 ± 9
aRefs. [6,19].
bThe value depends on the experimental conditions used.
cKinetically stabilized.and analyzed by means of Jasco software. For measurements above
250 nm, the cell path was 1 cm and for measurements in the 190–
250 nm region was 0.1 cm.
2.4. Kinetic measurements
The apparent kinetic parameters on diﬀerent amino acids as sub-
strate were determined in 100 mM sodium pyrophosphate buﬀer, pH
8.5, containing 40 lM FAD, at 25 C and air saturation, measuring
the oxygen consumption with a Hansatech oxygen electrode [11].
The rapid reaction measurements and the turnover experiments were
performed in 50 mM sodium pyrophosphate buﬀer, pH 8.3, containing
1% glycerol, at 25 C in a stopped-ﬂow BioLogic SFM-300 spectro-
photometer equipped with a J&M diode array detector [17]. Enzyme
monitored turnover data were analyzed according to the method de-
scribed by [18]. For reductive and oxidative half-reaction experiments,
the stopped-ﬂow instrument was made anaerobic by overnight equili-
bration with a sodium dithionite solution and then was rinsed with ar-
gon-equilibrated buﬀer. Reaction rates were calculated by extracting
traces at individual wavelengths (455 and 530 nm) and ﬁtting them
to a sum of exponentials equation using the program Biokine32 (Bio-
Logic). The program Specﬁt/32 (Spectrum Software Ass., USA) was
employed to simulate the experimental time courses.3. Results
3.1. Spectral properties of puriﬁed hDAAO
The recombinant protein is isolated as a holoenzyme show-
ing the typical absorbance spectrum of the FAD-containing
ﬂavoenzymes: absorbance maxima at 454, 372, and 278 nm
and a ratio of the near-UV (280 nm) and of the main visible
band (455 nm) of 10.6 (see Table 1 and Fig. 1). The absorp-
tion spectrum of oxidized hDAAO shows a marked depen-
dence on pH: at high pH values (P 10) a bathochromic shift
is observed for the near-UV band at 370 nm. This is consis-pkDAAOa RgDAAOa
11.3 12.6
9.4 10.6
90 94c
138 116
185 116
347 368
Isodesmic self-association Dimeric
Monomeric Monomeric
2 · 107 2 · 108
2.0 245
3500 110
Fig. 1. Absorbance spectrum of hDAAO in the free (—), benzoate-
complex (  ) and anthranilate-complex (- - -) oxidized form and in the
reduced form (—–—). The spectra of the hDAAO–ligand complexes
have been obtained starting from the stock enzyme solution (contain-
ing 40 lM free FAD, see Section 2) diluted 45-fold in plain buﬀer (see
below) and following the addition of 0.075 mM benzoate and 2.65 mM
anthranilate to 10 lM oxidized enzyme (the spectra were recorded
15 min after ligand addition). The spectrum of the reduced hDAAO
was measured 90 min after the anaerobic addition of 5 mM D-alanine.
Conditions. 20 mM Tris–HCl, pH 8.0, 5% glycerol, 5 mM 2-mercap-
toethanol at 15 C.
Fig. 2. Eﬀect of urea on hDAAO conformation. CD spectra were
recorded after the addition of increasing urea concentration (0–7.2 M);
each spectrum was determined on individual sample prepared by
mixing appropriate volumes of protein (0.1 mg protein/ml), 8 M urea
in buﬀer, and plain buﬀer (50 mM sodium pyrophosphate, pH 8.3), at
15 C. Inset: equilibrium denaturation curve from the CD signal at
220 nm.
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logical pH. The observed pKa value (10.30 ± 0.15) is higher
than that of free FAD and pkDAAO (10.0 and 9.4, respec-
tively). The enzyme tightly binds benzoate, a classical DAAO
inhibitor, resulting in the typical perturbation of the ﬂavin
spectrum reported in Fig. 1. A Kd of 7 ± 2 lM at pH 8.0
was estimated. The enzyme also binds anthranilate (Kd =
40 ± 10 lM), yielding the typical ‘‘charge-transfer’’ absorption
band centered around 580 nm (Fig. 1). When a sulﬁte covalent
adduct to the N(5) ﬂavin position is formed, the visible spec-
trum of the enzyme is bleached: a Kd of 64 ± 9 lM was esti-
mated. This reaction is prevented by the addition of 0.1 mM
benzoate.
The puriﬁed hDAAO is catalytically active as demonstrated
by the conversion of the oxidized form of the ﬂavin cofactor to
the reduced state following the addition of D-alanine under
anaerobic conditions (Fig. 1). Upon anaerobic photoreduc-
tion, the amount of the anionic semiquinone form of the ﬂavin
cofactor produced by hDAAO is largely dependent on the
experimental conditions used. At pH 8.0 and in the presence
of 20 mM Tris–HCl buﬀer, an amount of <5% of the semiqui-
none form was produced, while at pH 8.3 and in the presence
of 50 mM bicine buﬀer, an amount of 77% of the one-elec-
tron reduced form was formed. A large part of the semiqui-
none ﬂavin form produced under the latter conditions is
kinetically stabilized: following an overnight incubation, a
30% residual semiquinone form was observed (Table 1).
The midpoint redox potential of hDAAO was determined at
pH 8.0 by the equilibration method [13] using indigodisulfo-
nate as reference dye. For the two-electron transfer potential
an Em  100 ± 11 mV was estimated (Table 1). The addition
of 1 mM benzoate caused a 34-mV negative shift of the mid-
point redox potential.
3.2. Oligomeric state and stability of hDAAO holoenzyme
Gel-permeation chromatography experiments showed that
native hDAAO is a dimeric holoenzyme in the 1–24 mg pro-
tein/ml concentration range. The oligomerization state of the
holoenzyme form of hDAAO is similar to that of the yeast
DAAO and is signiﬁcantly diﬀerent to that of the closely re-
lated pkDAAO [6,19], for which the oligomerization state de-pends on the protein concentration. hDAAO shows a good
stability to urea denaturation (following the 220-nm CD signal
a Cm of 4.80 ± 0.15 M was determined, see Fig. 2) and to tem-
perature unfolding (Tm = 52 C).
3.3. FAD binding
hDAAO contains one molecule of non-covalently bound
FAD per protein monomer, which can be easily isolated from
the apoprotein by dialysis in the presence of 1 M KBr (with a
70% yield in terms of protein recovered). From changes in ﬂuo-
rescence intensity during the titration of the apoprotein with
FAD and from activity assays in the absence and in the presence
of exogenous FAD, aKd of 8 ± 2 · 106 Mwas estimated. Such
a value is in good agreement with the value determined previ-
ously [10] and signiﬁcantly higher than the one measured for
any other known DAAO (in the 107–108 M range, see Table
1), raising the question of the amount of active hDAAO present
in vivo. Interestingly, in the presence of a classical DAAO li-
gand such as 1 mM benzoate and under the same experimental
conditions, the Kd for FAD binding is signiﬁcantly lower
(=3 ± 1 · 107 M) and similar to that of pkDAAO [19].
A further main diﬀerence compared to known DAAOs is
evident during gel-permeation chromatography: the apopro-
tein form of the human ﬂavoprotein elutes as a single peak cor-
responding to a dimeric state while the apoprotein forms of
both pk- and RgDAAO are stable 40-kDa monomers
[16,19]. This indicates conservation of a large part of the
dimerization interface in the apoprotein form. In fact, the
hDAAO apoprotein maintains the secondary structure of the
holoenzyme (similar far-UV CD spectrum), while some
changes are evident in the near-UV CD spectrum, suggesting
alteration of the tertiary structure following FAD release (data
not shown).
3.4. Substrate speciﬁcity
The apparent kinetic parameters on D-serine, the putative
‘‘physiological’’ substrate of hDAAO, determined at 25 C
and 21% oxygen saturation, indicates that hDAAO possesses
a low catalytic eﬃciency and substrate aﬃnity (kcat,app = 3 s
1
and Km,app = 7.5 mM). Interestingly, a higher activity was
determined on D-alanine and on D-proline (Table 2). Even
D-aspartate can be oxidized by hDAAO, but the aﬃnity for
this substrate is very low (Km,app  2 M). The kinetic
G. Molla et al. / FEBS Letters 580 (2006) 2358–2364 2361parameters determined on D-alanine and D-serine are on the
same order of magnitude as those determined for pkDAAO
(Table 2) and do not explain how the human enzyme could eﬃ-
ciently bind and oxidize D-serine in vivo (its concentration
ranging from 10 to 300 nmol/g wet weight in peripheral tissues
and brain, respectively) [2]. Furthermore, even glycine (a neu-
rotransmitter that binds to NMDA receptors in a manner sim-
ilar to that of D-serine) is oxidized by hDAAO, but with a
signiﬁcantly lower eﬃciency (Table 2), whereas no activity is
evident using NMDA as substrate.
3.5. Kinetic mechanism
The kinetic mechanism of hDAAO was investigated both by
the enzyme monitored turnover method as a function of oxy-
gen concentration using D-alanine and D-serine as substrates
and by rapid kinetic measurements. Steady-state measure-
ments were performed by mixing the oxidized enzyme
aerobically with D-alanine (0.75–5 mM concentration range)
or D-serine (1–10 mM concentration range) and monitoring
the change in ﬂavin absorption at 455 nm (data not shown).
A rapid initial decrease in absorption was observed, amount-
ing to 10–15% of the total change, followed by a stationary
phase, whose duration depended on the initial D-amino acid
concentration, and which converted into the fully reduced en-
zyme as the ﬁnal state. In all cases, a slow decrease in the
absorbance is evident at longer times (due to the binding of
the free coenzyme to the apoprotein form present in the solu-
tion, see below), and was not considered for calculations. The
455-nm traces were analyzed as a function of oxygen concen-
tration according to [18]. Lineweaver–Burk plots at diﬀerent
substrate concentrations show a set of parallel lines pointing
to an apparent ping-pong kinetic mechanism or to formation
of a ternary complex with some of the rate constants suﬃ-
ciently small that the bimolecular term Ud -AA;O2 of the stea-
dy-state equation becomes negligible at high substrate
concentrations (see Eqs. (1), (2)):Table 2
Comparison of the substrate speciﬁcity of DAAO from diﬀerent
sources
hDAAO pkDAAOa RgDAAOb
D-Alanine
kcat,app (s
1) 5.2 6.4 85
Km,app (mM) 1.3 3.1 0.8
D-Serine
kcat,app (s
1) 3.0 5.8 40.7c
Km,app (mM) 7.5 41 13.7
c
D-Proline
kcat,app (s
1) 10.2 43.3 77.3
Km,app (mM) 8.5 2 21.5
Glycine
kcat,app (s
1) 0.9 b.d. 9.5c
Km,app (mM) 180 160
c
D-Aspartate
kcat,app (s
1) 6.7 b.d. 0.7
Km,app (mM) 2000 33.1
The apparent kinetic parameters were determined by the oxygen-
consumption assay at 21% oxygen saturation, pH 8.5 and at 25 C.
b.d., below detection.
aRef. [21].
bRef. [22].
cUnpublished results.et=v ¼ U0 þ Ud -Ala=½d -AA þ UO2=½O2
þ Ud -AA;O2=½d -AA½O2; ð1Þ
where kcat = 1/U0; Km,D-AA = UD-AA/U0; Km;O2 ¼ UO2=U0.
et
v
¼ k2 þ k4
k2  k4 þ
k1 þ k2
k1  k2½d -AA þ
k2 þ k2
k2  k3½O2
þ k1 þ k2
k1  k2  k3½d -AA½O2 . ð2Þ
The steady-state coeﬃcients conﬁrm the low activity and sub-
strate aﬃnity of hDAAO obtained at ﬁxed oxygen concentra-
tion (see Tables 2 and 3).
For reductive half-reaction experiments, 10 lM of enzyme
was anaerobically mixed with diﬀerent concentrations of D-
amino acid in the stopped-ﬂow instrument: the time course
of ﬂavin reduction at 455 nm shows three phases and the one
at 530 nm shows two phases (Fig. 3). This behavior is due to
two diﬀerent processes: the reduction of the ﬂavin bound to
the enzyme (ﬁrst and second phase, Eq. (3a)) and the reduction
of the ﬂavin following the slow binding of the free coenzyme to
the hDAAO apoprotein (third phase, Eq. (3b)):
E-FADox þD-AA ¢
k1
k1
E-FADox : D-AA ¢
k2
k2
E-FADred : IA
¢
k3
k3
E-FADred þ IA ð3aÞ
Apoproteinþ FADox ¢
kon
koff
E-FADox ð3bÞ
In fact, using a 10 lM enzyme solution (and because of the
weak binding of the ﬂavin cofactor to hDAAO) about 40% of
the enzyme is in the apoprotein form: this value nicely corre-
sponds to the amplitude of the third phase on the entire absor-
bance change at 455 nm (see Fig. 3). The observed rate
constants of the ﬁrst (rapid) phase exhibited saturation with
increasing D-amino acid concentration, while the second and
the third phase were insensitive to substrate concentration.
The ﬁrst phase corresponds to the ﬂavin reduction yielding a
charge-transfer complex between the reduced enzyme and the
product imino acid (IA) having a broad absorbance peak cen-
tered at 530 nm (see Eq. (3a) and spectrum 3 in Fig. 3 inset).
Analogously to pk- and RgDAAO [17,20], steps k1 and k1
were not observed spectrophotometrically, implying that sub-
strate binding did not aﬀect the oxidized ﬂavin chromophore
to a measurable extent. Interestingly, the rate of ﬂavin reduc-
tion (k2) is signiﬁcantly faster than the turnover number (see
Table 3), i.e., it is not rate limiting in catalysis. The second phase
corresponds to the imino acid release from the reduced enzyme
form (k3  0.6–0.9 s1) yielding the free reduced enzyme (spec-
trum 4 in Fig. 3 inset). We replicated the experimental spectral
time courses with Specﬁt/32 software (Fig. 3): the simulations
conﬁrm the values of the aforementioned kinetic parameters
and allowed to estimate the minimal values of k1 and k1
(=1.5 ± 0.5 · 104 M1 s1 and 100 ± 20 s1, respectively). The
same simulations conﬁrm that the third phase corresponds to
the slow ﬂavin reduction following the binding of the free oxi-
dized FAD (spectrum 2 in Fig. 3 inset) to the apoprotein form
present in the assay mixture (k  0.01 s1, Eq. (3b)).
For reoxidation experiments, the enzyme was ﬁrst reduced
with a small excess (2- or 3-fold) of substrate under anaerobic
conditions. The oxidative half-reaction was initially investi-
gated by reacting the free reduced form of hDAAO with buﬀer
Table 3
Comparison of the steady-state coeﬃcients, reductive and oxidative half-reaction speciﬁc rate constants of hDAAO, pkDAAO and RgDAAO on
D-alanine as substrate determined by rapid mixing techniques [17] at pH 8.3 and 25 C
hDAAO pkDAAOa RgDAAOb
Steady-state
Lineweaver–Burk plot Parallel Parallel Parallel
kcat (s
1) 14.7 ± 0.7 (6.3 ± 1.4) 10 350
Km,D-Ala (mM) 8.8 ± 0.3 (19.8 ± 3.4) 2.0 2.6
Km;O2 ðmMÞ 1.2 ± 0.3 (2.2 ± 0.7) 0.15 2.3
UD-Ala (M s · 103) 0.6 ± 0.1 (3.2 ± 0.7) 0.2 0.0074
UO2 ðM s  105Þ 8 ± 0.3 (0.35 ± 0.1) 1.5 0.0065
Reductive half-reaction
k2 (s
1) 180 ± 20 (117 ± 6) 4000 345
Kd,app (mM) 12.7 ± 2.8 (34.5 ± 3.2) 420 2.8
k3 (s
1) 0.6 ± 0.2 (0.9 ± 0.3) 0.02 2.8
Oxidative half-reaction
k4 (M
1 s1) · 104 1.7 ± 0.6 4.6 4.6
k5 (M
1 s1) · 104 12.5 ± 4.2 17 11
The Kd,app was obtained from the slope divided by the intercept in the double-reciprocal plot of the rate of reduction vs. D-amino acid concentration.
The values determined on D-serine as substrate are shown in parentheses. For hDAAO and pkDAAO kcat corresponds to k6, while for RgDAAO the
rate limiting step in catalysis is k2 (see Fig. 4).
aRef. [20].
bRef. [17].
Fig. 3. Time course of the anaerobic reduction of 10.4 lM hDAAO
by 5 mM D-alanine followed at 455 nm and 530 nm (j). Curve (—) is
the ﬁt for a triple (trace at 455 nm) or a double (trace at 530 nm)
exponential decay; curve (- - -) is the trace obtained from simulation
using the Specﬁt/32 software and based on the sequence of steps of
Eqs. (3a) and (3b), on spectra of colored species (see inset), and on the
rate constants reported in Table 3 and in the text (k1 =
1.5 · 104 M1 s1, k1 = 100 s1, k2 = 0.01 s1, and k3  0). Inset:
the spectra shown are those of the known oxidized hDAAO (1) and
oxidized free FAD (2), and those obtained by deconvolution of the
experimental data with Specﬁt/32 using a model according to the
sequence of steps reported in Eqs. (3a) and (3b): spectrum (3, —)
corresponds to the intermediate identiﬁed during the enzyme reduction
process (reduced enzyme  IA complex) and spectrum (4) is that of the
free reduced enzyme. Minor diﬀerences between the identiﬁed spectra
and the real ones depend on the presence of free FAD in the solution
(and because of the low Kd for coenzyme binding of hDAAO).
2362 G. Molla et al. / FEBS Letters 580 (2006) 2358–2364solutions equilibrated at increasing oxygen concentration (Eq.
(4a)): spectra were recorded during ﬂavin reoxidation (data not
shown). The time course of absorbance change at 455 nm was
monophasic and the observed rates depended linearly on oxy-
gen concentration and were extrapolated to the origin, consis-
tent with a second-order reaction in dioxygen. A reoxidation
rate constant of 1.7 ± 0.6 · 104 M1 s1 was calculated (Table
3). Subsequently, the rate of reoxidation of reduced enzyme
bound to the ﬁnal product imino acid was investigated. Unfor-
tunately, a reduced enzyme–imino acid complex cannot be
produced experimentally as it hydrolyzes in the presence ofwater. Since this compound is unstable in aqueous solution,
we tried to produce it by adding pyruvate and ammonium
chloride to the enzyme solution (analogously to that previously
performed for RgDAAO) [17]. The anaerobic titration of fully
reduced hDAAO using increasing concentrations of pyruvate
in the presence of 0.4 M ammonium chloride yielded the oxi-
dized enzyme form. This result demonstrates that the reductive
half-reaction is reversible (k2 in Eq. (3a) is small but it is dif-
ferent from zero). In order to produce a signiﬁcant percentage
of the E-FADred:IA complex in the reaction mixture, the reox-
idation reaction was performed with buﬀer containing 0.4 M
ammonium chloride and 20 or 50 mM pyruvate. Under these
conditions the absorbance increase at 455 nm was biphasic
(data not shown). The amplitude of the absorbance change
associated to each single phase does not depend on the oxygen
concentration, but it is largely dependent on the pyruvate con-
centration (the absorbance change associated to the fast phase
corresponded to 50% of the total change at 20 mM pyruvate
and 70% at 50 mM pyruvate). Both the observed rates de-
pended on the oxygen concentration. Our interpretation of this
ﬁnding is represented by Eq. (4): we assume that the E-FADred
and the E-FADred:IA forms are in rapid equilibrium and there-
fore that the reoxidation can start from both the free (Eq. (4a))
and the IA-complexed form (Eq. (4b)) of the reduced enzyme:k4 ≈ 1 x 104 M-1s-1
E-FADred + O2
E-FADox + H2O2
k5 = 1.2 x 105 M-1s-1
E-FADred:IA + O2 IA
(a)
(b)
ð4Þ
The reoxidation rate of the slow phase is in good agreement
with the value determined in the absence of pyruvate
Fig. 4. Kinetic scheme of the reaction of hDAAO. Lower loop:
ternary complex mechanism; upper loop: ping-pong mechanism. The
species not detected spectrophotometrically, but which were required
by the kinetic mechanism, are shown in parenthesis.
G. Molla et al. / FEBS Letters 580 (2006) 2358–2364 2363(=1.7 ± 0.6 · 104 M1 s1). On the other hand, the second-or-
der rate constant for the ﬁrst (rapid) phase is signiﬁcantly fas-
ter: k5 = 1.2 ± 0.4 · 105 M1 s1. This model of the oxidative
half-reaction was validated by simulation of the spectral time
courses using Specﬁt/32 software: a good simulation was only
obtained when a 1:1 and 1:2 ratio between E-FADred and E-
FADred:IA forms was used at 20 and 50 mM pyruvate, respec-
tively, which is in good agreement with the absorbance change
associated to the two phases (see above).
The combination of steady-state and pre-steady-state mea-
surements (see Table 3) indicates that: (i) hDAAO follows a
tertiary complex (sequential) kinetic mechanism (lower loop
of Fig. 4) since k3 is too slow to belong to the turnover kinetic
mechanism. This mechanism is similar to that observed with
pk- and RgDAAO with neutral substrates [17,20]; (ii) the ki-
netic parameters are on the same order of magnitude as those
determined for pkDAAO (the main diﬀerence is represented by
the rate of ﬂavin reduction, which is 20-fold slower in the hu-
man enzyme, see Tables 2 and 3); and (iii) the rate of product
release from the reoxidized enzyme form (k6) is the rate-limit-
ing step in catalysis, analogous to that observed for pkDAAO
[20].4. Conclusions
In this work we reported on the expression of fairly large
amounts of hDAAO, a stable and active holoenzyme. This
human enzyme shows the classical properties of the dehydro-
genase-oxidase class of ﬂavoproteins (it reacts quickly with
oxygen in the reduced state, stabilizes the anionic red semiqui-
none, and binds sulﬁte covalently) and shares these properties
with both pk- and RgDAAO [6,19]. On the other hand,
hDAAO possesses some peculiar properties. In particular,
binding of the FAD cofactor to the human enzyme in the ab-
sence of an active site ligand is the weakest among known
DAAOs, and it is also the only DAAO apoprotein present in
solution as a dimer. From the kinetic point of view, hDAAO
shows the same rate limiting step (represented by the product
release from the reoxidized enzyme) and the same sequential
mechanism reported for pkDAAO on neutral D-amino acids,
but a signiﬁcant slower rate of ﬂavin reduction [20]. In com-
parison to the yeast DAAO, and even if the two enzymesshows the same kinetic mechanism, hDAAO possesses a diﬀer-
ent rate limiting step in catalysis and a 10-fold lower activity
[6,17]. These results contribute to further elucidating the eﬀect
of the inferred binding protein pLG72 on the stability and
kinetics of the reaction catalyzed by DAAO in human brain
with the aim of designing speciﬁc drugs that could alter the
properties of this key enzyme in glutamatergic neurotransmis-
sion.Acknowledgements: This work was supported by Grants from Italian
MIUR to M.S. Pilone (Prot. 2004058243), from FAR to M.S. Pilone
and L. Pollegioni, and from Fondazione CARIPLO to L. Pollegioni.References
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